
Metvian G 2mg/500mg Tablet SR
Marketer
Vivichem Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Metvian G 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can lead to elevated glucose, risking complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Metvian G 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metvian G 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metvian G 2mg/500mg Sustained-Release tablet should be administered with a meal.
Common Side effects of Metvian G 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metvian G 2mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metvian G 2mg/500mg Extended-Release Tablets with food.
How Metvian G 2mg/500mg Tablet SR works:
Metvian G 2mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metvian G 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metvian G 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Metvian G 2mg/500mg tablets are contraindicated during lactation. Evidence indicates a potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metvian G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Metvian G 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Metvian G 2mg/500mg Tablet SR cautiously, as dose modification may be necessary. Medical advice is recommended. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metvian G 2mg/500mg Tablet SR :
Should you forget a Metvian G 2mg/500mg Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metvian G 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
